Analyst Ratings for MindMed (MNMD)
MNMD Rating Summary
MNMD Price Target Summary
- Highest: $36.00 (Roth/MKM)
- Lowest: $9.00 (Canaccord Genuity)
- Average: $23.20
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$23.20 (+175.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$23.20 (+175.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/15/2024 | Leerink Partners | Rudy Li | New Coverage | Outperform (N/A) |
20.00 (N/A) |
9.67 (8.42) |
-12.93% | Details |
| 12/5/2023 | Canaccord Genuity » Updated 3/7/2024 |
Sumart Kulkami | New Coverage | Buy (N/A) |
9.00 (16.00) |
3.61 (8.42) |
133.24% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
